We are live on ! Find out more
SC

Scholtz & Company Portfolio holdings

AUM $195M
1-Year Est. Return 12.04%
This Fund
S&P 500
This Quarter Est. Return
+3.53%
1 Year Est. Return
+12.04%
3 Year Est. Return
+82.55%
5 Year Est. Return
+94.25%
10 Year Est. Return
+790.35%
AUM
$228M
AUM Growth
-$212K
Cap. Flow
-$4.85M
Cap. Flow %
-2.13%
Top 10 Hldgs %
51.84%
Holding
54
New
2
Increased
20
Reduced
27
Closed
3

Top Buys

Rank Stock Value
1
VVV icon
Valvoline
VVV
+$2.75M
2
ETN icon
Eaton
ETN
+$2.22M
3
DXCM icon
DexCom
DXCM
+$2M
4
PM icon
Philip Morris
PM
+$1.23M
5
AMZN icon
Amazon
AMZN
+$1.15M

Top Sells

Rank Stock Value
1
OWL icon
Blue Owl Capital
OWL
+$3.2M
2
UNH icon
UnitedHealth
UNH
+$2.99M
3
VCEL icon
Vericel Corp
VCEL
+$2.15M
4
TDG icon
TransDigm Group
TDG
+$1.98M
5
PWR icon
Quanta Services
PWR
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 23.26%
2 Financials 17.2%
3 Consumer Discretionary 14.41%
4 Communication Services 12.54%
5 Industrials 11.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
51
Berkshire Hathaway Class B
BRK.B
$1.1T
-559
Closed -$272K
OWL icon
52
Blue Owl Capital
OWL
$6.96B
-166,790
Closed -$3.2M
VCEL icon
53
Vericel Corp
VCEL
$2.35B
-50,573
Closed -$2.15M

Similar funds

Scholtz & Company's Q3 2025 Portfolio in Review

As of Q3 2025, Scholtz & Company held 54 positions worth $228M, down 0.09% from $228M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Scholtz & Company's Q3 2025 filing shows 2 new, 20 increased, 27 reduced and 3 closed positions. Its largest new stake was Valvoline: 72,165 shares worth $2.59M. The largest sale was Blue Owl Capital, an estimated $3.2M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Scholtz & Company's largest Q3 2025 buy was Valvoline: 72,165 shares worth $2.59M.
  • Scholtz & Company added most to DexCom in Q3 2025, an estimated $2M increase.
  • Scholtz & Company's biggest Q3 2025 reduction was UnitedHealth, cutting an estimated $2.99M.
  • Scholtz & Company fully exited Blue Owl Capital in Q3 2025, selling an estimated $3.2M.
  • Scholtz & Company's ten largest holdings make up 52% of its $228M portfolio in Q3 2025.
  • Scholtz & Company opened 2 new positions and closed 3 in Q3 2025.
  • Scholtz & Company's portfolio value fell 0.09% quarter-over-quarter to $228M.

Based on Scholtz & Company's 13F filing for Q3 2025, filed 12 Nov 2025.